Qiangxin Mixture

Qiangxin Mixture is a traditional Chinese medicine (TCM) herbal compound developed by the Shanghai Hospital of Traditional Chinese Medicine. It is specifically utilized for the treatment of patients in the vulnerable phase of heart failure, which is the high-risk period following discharge after an episode of acute decompensation. The mixture is typically administered as an adjunctive therapy to standard-of-care Western medicine. Its therapeutic goals include improving cardiac function, alleviating clinical symptoms such as dyspnea and edema, and reducing the rate of rehospitalization. As a complex herbal formulation, it is believed to exert its effects through multiple mechanisms, including the enhancement of cardiac contractility and the promotion of diuresis.

Other names

Qiangxin Heji